Co-Authors
This is a "connection" page, showing publications co-authored by Andrea Cossarizza and Giovanni Guaraldi.
Connection Strength
3.970
-
Geriatric-HIV medicine: A science in its infancy. Virulence. 2017 07 04; 8(5):504-507.
Score: 0.710
-
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection. Nat Commun. 2021 07 29; 12(1):4677.
Score: 0.240
-
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
Score: 0.234
-
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
Score: 0.233
-
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
Score: 0.233
-
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
Score: 0.229
-
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
Score: 0.228
-
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020 12 07; 12(12):e13001.
Score: 0.228
-
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol. 2020 09; 50(9):1283-1294.
Score: 0.224
-
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
Score: 0.223
-
Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
Score: 0.222
-
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm. Cytometry A. 2020 07; 97(7):668-673.
Score: 0.219
-
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health. Cytometry A. 2020 04; 97(4):340-343.
Score: 0.218
-
Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir Ther. 2005; 10 Suppl 2:M91-9.
Score: 0.076
-
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
Score: 0.060
-
Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies. Clin Infect Dis. 2021 07 01; 73(1):e252-e255.
Score: 0.060
-
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients. Sci Rep. 2021 06 16; 11(1):12716.
Score: 0.059
-
Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. Nat Commun. 2021 05 10; 12(1):2593.
Score: 0.059
-
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
Score: 0.058
-
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study. Multidiscip Respir Med. 2021 Jan 15; 16(1):737.
Score: 0.058
-
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951043.
Score: 0.054
-
HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell : CD8+ cell ratio or length of efficient treatment. AIDS. 2017 06 19; 31(10):1387-1392.
Score: 0.045